microdose glp-1 menopause Agonists in Perimenopause: Unique Risks and Potential Opportunities Microdose GLP1 for perimenopause weight

The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(-/-) and LDLr(-/-) mice by a mechanism that includes inflammatory pathways

In December 2025, Novo Nordisk received FDA approval for an oral formulation of Wegovy that demonstrated weight loss effects similar to those of the Wegovy injection

These actions collectively contribute to improved glucose control and weight loss, making GLP-1 peptides a valuable tool for individuals seeking to manage their weight effectively

Prescription grade health care, from anywhere

She holds dual master's degrees from Tufts University and approaches care without a weight-centric lens.